Literature DB >> 27171555

Culturing Uveal Melanoma Cells.

Martina Angi1, Mieke Versluis2, Helen Kalirai1.   

Abstract

A major challenge in cancer research is the use of appropriate models with which to study a specific biological question. Cell lines have long been used to study cellular processes and the effects of individual molecules because they are easy to use, grow rapidly, produce reproducible results and have a strong track record in research. In uveal melanoma in particular, the absence of animal models that faithfully replicate the behavior of the human disease has propagated the generation and use of numerous cell lines by individual research groups. This in itself, however, can be viewed as a problem due to the lack of standardization when characterizing these entities to determine how closely they reflect the genetic and phenotypic characteristics of this disease. The alternative is to use in vitro primary cultures of cells obtained directly from uveal melanoma patient samples, but this too has its difficulties. Primary cell cultures are difficult to use, hard to obtain and can show considerable heterogeneity. In this article, we review the following: (1) the uveal melanoma cell lines that are currently available, discussing the importance of establishing a bank of those that represent the molecular heterogeneity of uveal melanoma; (2) the methods used to isolate and perform short-term cultures of primary uveal melanoma cells, and (3) the establishment of 3D tissue culture models that bridge the gap between 2D in vitro systems and in vivo models with which to dissect cancer biology and perform therapeutic screens.

Entities:  

Keywords:  Culture models; Primary cell cultures; Uveal melanoma

Year:  2015        PMID: 27171555      PMCID: PMC4847689          DOI: 10.1159/000370150

Source DB:  PubMed          Journal:  Ocul Oncol Pathol        ISSN: 2296-4657


  29 in total

1.  Frequent mutation of BAP1 in metastasizing uveal melanomas.

Authors:  J William Harbour; Michael D Onken; Elisha D O Roberson; Shenghui Duan; Li Cao; Lori A Worley; M Laurin Council; Katie A Matatall; Cynthia Helms; Anne M Bowcock
Journal:  Science       Date:  2010-11-04       Impact factor: 47.728

2.  Establishment of cell lines of uveal melanoma. Methodology and characteristics.

Authors:  D M Albert; M A Ruzzo; M A McLaughlin; N L Robinson; J L Craft; J Epstein
Journal:  Invest Ophthalmol Vis Sci       Date:  1984-11       Impact factor: 4.799

3.  Abnormal cell cycle regulation in primary human uveal melanoma cultures.

Authors:  María Pardo; Antonio Piñeiro; María de la Fuente; Angel García; Sripadi Prabhakar; Nicole Zitzmann; Raymond A Dwek; Manuel Sánchez-Salorio; Fernando Domínguez; Carmen Capeans
Journal:  J Cell Biochem       Date:  2004-11-01       Impact factor: 4.429

4.  Inverse expression states of the BRN2 and MITF transcription factors in melanoma spheres and tumour xenografts regulate the NOTCH pathway.

Authors:  A E Thurber; G Douglas; E C Sturm; S E Zabierowski; D J Smit; S N Ramakrishnan; E Hacker; J H Leonard; M Herlyn; R A Sturm
Journal:  Oncogene       Date:  2011-02-28       Impact factor: 9.867

5.  Multicellular spheroids as an in vitro model in experimental oncology: applications in translational medicine.

Authors:  Divya Khaitan; B S Dwarakanath
Journal:  Expert Opin Drug Discov       Date:  2006-12       Impact factor: 6.098

6.  Pyrophosphorolysis detects B-RAF mutations in primary uveal melanoma.

Authors:  Willem Maat; Emine Kilic; Gré P M Luyten; Annelies de Klein; Martine J Jager; Nelleke A Gruis; Pieter A Van der Velden
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-01       Impact factor: 4.799

7.  Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations.

Authors:  X Chen; Q Wu; L Tan; D Porter; M J Jager; C Emery; B C Bastian
Journal:  Oncogene       Date:  2013-10-21       Impact factor: 9.867

8.  Impact of combined mTOR and MEK inhibition in uveal melanoma is driven by tumor genotype.

Authors:  Alan L Ho; Elgilda Musi; Grazia Ambrosini; Jayasree S Nair; Shyamprasad Deraje Vasudeva; Elisa de Stanchina; Gary K Schwartz
Journal:  PLoS One       Date:  2012-07-10       Impact factor: 3.240

9.  Characterization of three cell lines derived from fine needle biopsy of choroidal melanoma with metastatic outcome.

Authors:  Barry L Burgess; Nagesh P Rao; Ascia Eskin; Stanley F Nelson; Tara A McCannel
Journal:  Mol Vis       Date:  2011-02-25       Impact factor: 2.367

10.  Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation.

Authors:  Maria Vinci; Sharon Gowan; Frances Boxall; Lisa Patterson; Miriam Zimmermann; William Court; Cara Lomas; Marta Mendiola; David Hardisson; Suzanne A Eccles
Journal:  BMC Biol       Date:  2012-03-22       Impact factor: 7.431

View more
  5 in total

1.  Characterization of luteinizing hormone-releasing hormone receptor type I (LH-RH-I) as a potential molecular target in OCM-1 and OCM-3 human uveal melanoma cell lines.

Authors:  Eva Sipos; Nikoletta Dobos; David Rozsa; Klara Fodor; Gabor Olah; Zsuzsanna Szabo; Lorant Szekvolgyi; Andrew V Schally; Gabor Halmos
Journal:  Onco Targets Ther       Date:  2018-02-22       Impact factor: 4.147

Review 2.  Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions.

Authors:  Nuno Jorge Lamas; Arnaud Martel; Sacha Nahon-Estève; Samantha Goffinet; Adam Macocco; Corine Bertolotto; Sandra Lassalle; Paul Hofman
Journal:  Cancers (Basel)       Date:  2021-12-25       Impact factor: 6.639

Review 3.  Mouse models of uveal melanoma: Strengths, weaknesses, and future directions.

Authors:  Jackson R Richards; Jae Hyuk Yoo; Donghan Shin; Shannon J Odelberg
Journal:  Pigment Cell Melanoma Res       Date:  2020-01-22       Impact factor: 4.693

4.  Characterization of Uveal Melanoma Cell Lines and Primary Tumor Samples in 3D Culture.

Authors:  Karen Aughton; Haleh Shahidipour; Luna Djirackor; Sarah E Coupland; Helen Kalirai
Journal:  Transl Vis Sci Technol       Date:  2020-06-29       Impact factor: 3.283

Review 5.  MicroRNAs and Uveal Melanoma: Understanding the Diverse Role of These Small Molecular Regulators.

Authors:  Karen Aughton; Helen Kalirai; Sarah E Coupland
Journal:  Int J Mol Sci       Date:  2020-08-06       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.